Information Library
Results for: White Papers - Endocrinology - Phase II/III
To learn more about Quintiles’ services, you may broaden or narrow your search by selecting the topics at left.
- Sort by:
- Recently Added
- Title
-
EMA’s Guidance on New Antidiabetic Drug Development
May 12, 2010
Assessing the EMA’s Guidance on New Antidiabetic Drug Development In January 2010, the European Medicines Agency (EMA) issued a draft guideline on antidiabetic drug development -
New FDA Guidance on Antidiabetic Therapies
December 11, 2009
Understanding the FDA Guidance on Assessing Cardiovascular Risks for new Antidiabetic Therapies. Learn what FDA cardiac safety requirements may mean for your development program.
Page 1 of 1 (2 results)
